BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Clinical trial NCT02337907 · COMPLETED

Trial details

NCT number: NCT02337907
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2015-01-21
Primary completion: 2017-09-15
Enrollment: 329

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.